Author

Amy Forst

Observed names: A Forst, A. Forst

OpenAlex ID: A5046562057

Assessment of the Consistency of Absorption of Dihydroergotamine Following Oral Inhalation: Pooled Results from Four Clinical Studies

2012 · Donald J. Kellerman, Amy Forst, et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 22

Lack of drug interaction between the migraine drug MAP0004 (orally inhaled dihydroergotamine) and a CYP3A4 inhibitor in humans

2011 · D Kellerman, S Kori, et al. · Cephalalgia · 22

Postpartum mood disorders: Results of an online survey

2007 · Russ Curtis, Phyllis Robertson, et al. · Counselling and Psychotherapy Research · 9

Nausea Associated with Dihydroergotamine Is a Function of Maximum Concentration and Not Route of Administration (P03.238)

2012 · D. Kellerman, S. Kori, et al. · Neurology · 2

A Drug Interaction Study Assessing the Effects of CYP3A4 Inhibition on the Pharmacokinetics of MAP0004, an Orally Inhaled Formulation of Dihydroergotamine in Healthy Volunteers (P03.228)

2012 · A. Forst, D. Kellerman, et al. · Neurology

Works count: 5

Citation count: 55

H-index: 3

I10-index: 2